|
Mr. Booth has been a Director of Millipore since 2004 and is currently Lead Director.
Mr. Booth received an undergraduate degree from Northwest Missouri State University in 1967 and holds an honorary Doctor of Science degree. He received his Certified Public Accounting (C.P.A.) designation in 1972.
From 1967 to1968 Mr. Booth practiced public accounting with McGladrey & Pullen. In 1968 he joined Kwik-Way Industries Inc. a manufacturer of precision machine tools for the automotive after-market as corporate controller and subsequently became Vice President of Finance. In 1975 Mr. Booth joined Den-Tal-Ez Inc. a manufacturer of major equipment for dental offices as Vice President of Finance and subsequently became Executive Vice President responsible for U.S. operations.
Syntex Inc. acquired Den-Tal-Ez Inc. in 1979 and Mr. Booth became President of Syntex Dental Products Inc. in 1981. Mr. Booth was with Syntex Inc. primarily a pharmaceutical company from 1979 to1995 where he held a variety of positions including serving as President Syntex Dental Products from 1981to1986 and President of Syntex Inc. Canada from 1986 to1991. From 1991to1992 he served as an area Vice President of Syntex Inc. Mr. Booth served as the President of Syntex Pharmaceuticals Pacific from 1992 to1993. He served as Vice President of Syntex Corporation from 1992 to mid-1995 including being President of Syntex Laboratories Inc. Syntex's U.S. pharmaceuticals business.
Mr. Booth was President Chief Operating Officer and a member of the Board of Directors of Human Genome Sciences Inc. a global biopharmaceutical company from July 1995 until October 1998. From 1998 until his retirement at the end of 2003 Mr. Booth was President and Chief Operating Officer of MedImmune Inc. a biotechnology company. Mr. Booth was a member of the Board of Directors of MedImmune Inc. from 1998 until March 2005.
Mr. Booth has been active in the U.S. pharmaceutical industry organizations and is the past chairman of the Pharmaceuticals Manufacturers Association of Canada. Mr. Booth currently serves on the board of Ventria BioScience and is Chairman of the Boards of Prestwick Pharmaceuticals Inc. and PRA International Inc. Mr. Booth is active in many educational and philanthropic causes including the establishment of The Melvin and Valorie Booth College of Business and Professional Studies at Northwest Missouri State University. | 